Report Highlights
The global market for bronchitis treatments is estimated to grow from $5.8 billion in 2022 to $6.9 billion in 2027, with a compound annual growth rate (CAGR) of 3.5% for the period of 2022-2027.
Report Includes
- 35 total tables
- An overview of the global markets for the treatment options for bronchitis
- Analyses of the global market trends, with market revenue data and sales figures for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the present and future strategies of the companies in the development of drugs and related treatment options for bronchitis, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size for bronchitis treatment, and corresponding market share analysis on the basis of disease type, drug class, treatment options, and geographic region
- Updated information on key market drivers and opportunities, industry shifts and regulations, and other demographic factors that will influence this market demand in the coming years (2022-2027)
- Insight into the patent grants and intellectual property aspects of the bronchitis treatment marketplace
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading pharmaceutical players, including AstraZeneca, Bayer AG, Cipla Inc., Sanofi and Pfizer Inc.
Report Scope
This study offers a global view of the treatment options for bronchitis in the market. This report analyzes and assesses the types of bronchitis, such as acute and chronic. It also provides information regarding different drugs classes, including antibiotics, anti-inflammatories and bronchodilators.
BCC Research analyzes and makes projections for each market and its segmentation, the regulatory environment, pipeline drugs and future aspects. The report also includes the impact of COVID-19 and profiles of leading companies in the bronchitis treatment market, including AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Cipla Inc., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.
The report covers the major markets of North America and Europe, as well as emerging markets, such as India, China, Japan and South Korea.
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||
| Base year market size | $5.6 billion | ||||||||||||
| Market size forecast | $6.9 billion | ||||||||||||
| Growth rate | CAGR of 3.5% from 2022 to 2027 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | Type, Drug Class | ||||||||||||
| Regions covered | North America, Europe, Asia Pacific, South America, and Middle East and Africa | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Pulmonary Drug Delivery Systems: Technologies and Global Markets
The global pulmonary drug delivery systems market should reach $76.9 billion by 2027 from $57.4 billion in 2022 at a compound annual growth rate (CAGR) of 6.0% for the forecast period of 2022 to 2027.
Anesthesia and Respiratory Devices: Global Markets
The global anesthesia and respiratory devices market should reach $36.2 billion by 2022 and more than $51 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets
The global market for nebulizers, inhalers and respirators has reached nearly $11.2 billion and $12.4 billion in 2013 and 2014, respectively. This market is expected to grow at compound annual growth rate (CAGR) of 8.9% to reach $19.0 billion in 2019.
Recent Reports
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Global Markets for Vaccine Technologies
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
Chagas Disease: American trypanosomiasis Market
The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
Flame Retardant Chemicals: Technologies and Global Markets
The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.
Biorefinery Products: Global Markets
The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Electric Vehicle Charging: Infrastructure and Global Markets
The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More